Nanotechnology allows the creation and use of functionalized structures, devices, and systems that take advantage of specific properties of matter that exist at the nanoscale. The integration of biomolecular engineering, nanotechnology, and biology is expected to produce major breakthroughs in cancer diagnostics and therapeutics. Due to the size-compatibility of nano-scale structures with proteins and nucleic acids, the design, synthesis and application of nanoprobes, nanocarriers and nanomachines provide unprecedented opportunities for achieving a better control of biological processes, and drastic improvements in disease detection, therapy, and prevention.
Bioengineers at Rice have been advancing nanotechnology innovations for more specific and effective disease diagnosis and treatment, and translating the nanomedicine approaches to address unmet needs in medicine.
Rice BIOE researchers working in this key application area:
Gang Bao, PhD
Kevin McHugh, PhD
Antonios Mikos, PhD
Junghae Suh, PhD
Omid Veiseh, PhD
David Zhang, PhD